<DOC>
	<DOCNO>NCT01095627</DOCNO>
	<brief_summary>This study aim evaluate whether number size exhale particle change increase decrease bronchial constriction subject mild intermittent asthma .</brief_summary>
	<brief_title>Characterization Aerosol Generation Transport Human Lung</brief_title>
	<detailed_description>Particle emission demonstrate high reproducibility within subject between-subject-variability large . Methacholine challenge subject mild intermittent asthma provide data repetitive measurement subject variable airflow obstruction .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>1 . Male female subject , age 18 65 year . 2 . Physician diagnosis mild intermittent allergic asthma ( GINA I accord GINA guidelines9 ) . 3 . Normal lung function parameter baseline ( FEV1 &gt; 80 % predict ) 4 . Non smoker smoker history le 10 pack year smoke last 12 month . 5 . Able willing give write informed consent 6 . Women consider inclusion : pregnant , confirmed pregnancy test , nurse nonchild bear potential ( i.e . physiologically incapable become pregnant , include female premenarchial postmenopausal , document proof hysterectomy tubal ligation , meet clinical criterion menopause amenorrhoeic 1 year prior screen visit ) childbearing potential use highly effective method contraception entire study ( vasectomized partner , sexual abstinence lifestyle female complete abstinence intercourse two week prior study least 72 hour end study , implant , injectables , combine oral contraceptive , hormonal IUDs , doublebarrier method , i.e . double combination IUD , condom spermicidal gel , diaphragm , sponge , cervical cap ) â€¢ Available complete study measurement 1 . History low respiratory tract infection four week prior inform consent visit . 2 . Past present disease , judge investigator , may affect outcome study . These disease include , limited , cardiovascular disease , malignancy , hepatic disease , renal disease , hematological disease , neurological disease , endocrine disease pulmonary disease ( include confine chronic bronchitis , emphysema , tuberculosis , bronchiectasis cystic fibrosis ) . 3 . Regular intake prescribe counter medication . Exceptions include paracetamol pain relief , oral contraceptive medication , hormonal replacement therapy , dietary vitamin supplement , short act beta mimetics ( SABA ) need basis . 4 . Use antiinflammatory medication include systemic inhaled corticosteroid within last four week . 5 . Any history lifethreatening asthma , define asthma episode require intubation and/or associate hypercapnea , respiratory arrest hypoxic seizure . 6 . Conditions factor , would make subject unlikely able undergo methacholine challenge . 7 . Conditions provide contraindication methacholine challenge test uncontrolled arterial hypertension , know aortic aneurysm , myocardial infarction stroke within three month prior study , current use cholinesterase inhibitor medication . 8 . Inability perform acceptablequality spirometry . 9 . History drug alcohol abuse . 10 . Participation another clinical trial 30 day prior enrolment . 11 . Suspected inability understand protocol requirement , instruction studyrelated restriction , nature , scope , possible consequence study . 12 . Risk noncompliance study procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>